Ngā hua rapu kaituhi

1

N-Methyl-D-aspartate Receptor Subtype Mediated Bidirectional Control of p38 Mitogen-activated Protein Kinase mā Elisa A. Waxman, David R. Lynch

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia mā David R. Lynch, Susan Perlman, Thomas Meier

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Predictors of loss of ambulation in Friedreich's ataxia mā Christian Rummey, Jennifer Farmer, David R. Lynch

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Interactions of Postsynaptic Density-95 and the NMDA Receptor 2 Subunit Control Calpain-Mediated Cleavage of the NMDA Receptor mā Yi Dong, Elisa A. Waxman, David R. Lynch

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Phenotypic variation of <i>FXN</i> compound heterozygotes in a Friedreich ataxia cohort mā Megan M. Shen, Christian Rummey, David R. Lynch

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate Receptor mā Michael J. Gallagher, Hui Huang, Dolan B. Pritchett, David R. Lynch

I whakaputaina 1996

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability mā Hong Lin, Ariel A. Jacobi, Stewart A. Anderson, David R. Lynch

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Central Nervous System Therapeutic Targets in Friedreich Ataxia mā Ian H. Harding, David R. Lynch, Arnulf H. Koeppen, Massimo Pandolfo

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
9

Antigenic and mechanistic characterization of anti‐ <scp>AMPA</scp> receptor encephalitis mā Amy J. Gleichman, Jessica A. Panzer, Bailey Baumann, Josep Dalmau, David R. Lynch

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: Implications for neuropsychiatric diseases mā Hong Lin, Fu‐Chun Hsu, Bailey Baumann, Douglas A. Coulter, David R. Lynch

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Friedreich Ataxia: Clinical Features and New Developments mā Medina Keita, Kellie McIntyre, Layne N. Rodden, Kim Schadt, David R. Lynch

I whakaputaina 2022

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
12

Anti-NMDA Receptor Encephalitis Antibody Binding Is Dependent on Amino Acid Identity of a Small Region within the GluN1 Amino Terminal Domain mā Amy J. Gleichman, Lynn A. Spruce, Josep Dalmau, Steven H. Seeholzer, David R. Lynch

I whakaputaina 2012

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

A patient with encephalitis associated with NMDA receptor antibodies mā Lauren Sansing, Erdem Tüzün, Melissa W. Ko, Jennifer Baccon, David R. Lynch, Josep Dalmau

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection mā Amy Salovin, Jason Glanzman, Kylie Roslin, Thaís Armangué, David R. Lynch, Jessica A. Panzer

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Friedreich Ataxia: Multidisciplinary Clinical Care mā David R. Lynch, Kim Schadt, Elizabeth Kichula, Shana E. McCormack, Kimberly Y. Lin

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
16

Comprehensive analysis of gene expression patterns in Friedreich's ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers mā Jill S. Napierala, Yanjie Li, Yue Lu, Kevin Lin, Lauren Hauser, David R. Lynch, Марек Напиерала

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers mā Ricarda White, Yue Hua, Bernd W. Scheithauer, David R. Lynch, Elizabeth P. Henske, Peter B. Crino

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia mā Hong Lin, Fu‐Chun Hsu, Bailey Baumann, Douglas A. Coulter, Stewart A. Anderson, David R. Lynch

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Somatic instability of the expanded GAA repeats in Friedreich’s ataxia mā Ashlee Long, Jill S. Napierala, Urszula Polak, Lauren Hauser, Arnulf H. Koeppen, David R. Lynch, Марек Напиерала

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

A rapid, noninvasive immunoassay for frataxin: Utility in assessment of Friedreich ataxia mā Éric Deutsch, Avni Santani, Susan Perlman, Jennifer Farmer, Catherine A. Stolle, Michael F. Marusich, David R. Lynch

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - David R. Lynch

N-Methyl-D-aspartate Receptor Subtype Mediated Bidirectional Control of p38 Mitogen-activated Protein Kinase mā Elisa A. Waxman, David R. Lynch

A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia mā David R. Lynch, Susan Perlman, Thomas Meier

Predictors of loss of ambulation in Friedreich's ataxia mā Christian Rummey, Jennifer Farmer, David R. Lynch

Interactions of Postsynaptic Density-95 and the NMDA Receptor 2 Subunit Control Calpain-Mediated Cleavage of the NMDA Receptor mā Yi Dong, Elisa A. Waxman, David R. Lynch

Phenotypic variation of <i>FXN</i> compound heterozygotes in a Friedreich ataxia cohort mā Megan M. Shen, Christian Rummey, David R. Lynch

Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate Receptor mā Michael J. Gallagher, Hui Huang, Dolan B. Pritchett, David R. Lynch

D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability mā Hong Lin, Ariel A. Jacobi, Stewart A. Anderson, David R. Lynch

Central Nervous System Therapeutic Targets in Friedreich Ataxia mā Ian H. Harding, David R. Lynch, Arnulf H. Koeppen, Massimo Pandolfo

Antigenic and mechanistic characterization of anti‐ <scp>AMPA</scp> receptor encephalitis mā Amy J. Gleichman, Jessica A. Panzer, Bailey Baumann, Josep Dalmau, David R. Lynch

Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: Implications for neuropsychiatric diseases mā Hong Lin, Fu‐Chun Hsu, Bailey Baumann, Douglas A. Coulter, David R. Lynch

Friedreich Ataxia: Clinical Features and New Developments mā Medina Keita, Kellie McIntyre, Layne N. Rodden, Kim Schadt, David R. Lynch

Anti-NMDA Receptor Encephalitis Antibody Binding Is Dependent on Amino Acid Identity of a Small Region within the GluN1 Amino Terminal Domain mā Amy J. Gleichman, Lynn A. Spruce, Josep Dalmau, Steven H. Seeholzer, David R. Lynch

A patient with encephalitis associated with NMDA receptor antibodies mā Lauren Sansing, Erdem Tüzün, Melissa W. Ko, Jennifer Baccon, David R. Lynch, Josep Dalmau

Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection mā Amy Salovin, Jason Glanzman, Kylie Roslin, Thaís Armangué, David R. Lynch, Jessica A. Panzer

Friedreich Ataxia: Multidisciplinary Clinical Care mā David R. Lynch, Kim Schadt, Elizabeth Kichula, Shana E. McCormack, Kimberly Y. Lin

Comprehensive analysis of gene expression patterns in Friedreich's ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers mā Jill S. Napierala, Yanjie Li, Yue Lu, Kevin Lin, Lauren Hauser, David R. Lynch, Марек Напиерала

Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers mā Ricarda White, Yue Hua, Bernd W. Scheithauer, David R. Lynch, Elizabeth P. Henske, Peter B. Crino

Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia mā Hong Lin, Fu‐Chun Hsu, Bailey Baumann, Douglas A. Coulter, Stewart A. Anderson, David R. Lynch

Somatic instability of the expanded GAA repeats in Friedreich’s ataxia mā Ashlee Long, Jill S. Napierala, Urszula Polak, Lauren Hauser, Arnulf H. Koeppen, David R. Lynch, Марек Напиерала

A rapid, noninvasive immunoassay for frataxin: Utility in assessment of Friedreich ataxia mā Éric Deutsch, Avni Santani, Susan Perlman, Jennifer Farmer, Catherine A. Stolle, Michael F. Marusich, David R. Lynch

Ngā utauta rapu:

Ngā marau whai pānga